Search results
Cancer causer or heartburn healer? Lawyers make closing pitches in first jury trial over Zantac ...
Chicago Sun-Times· 18 hours agoA popular heartburn drug with an active ingredient that degrades into a carcinogen so virulent “It’s the ‘Terminator’ of cancer.” Or a safe and effective ...
Roche (RHHBY) Cancer Drug Gets Breakthrough Therapy Designation
Zacks via Yahoo Finance· 2 days agoRoche's (RHHBY) inavolisib gets Breakthrough Therapy Designation in the United States for advanced...
Guardant colon cancer test struggles to detect non-cancerous tumors, FDA says
MedTech Dive via Yahoo Finance· 1 day agoA Food and Drug Administration advisory panel will evaluate whether a blood test from Guardant...
Self-Screening Approved By FDA For Cervical Cancer | Newswise
Newswise· 12 hours agoA way to self-collect a sample to prevent cervical cancer is now available for women. The test to self-screen for human papillomavirus (HPV) was approved by the U.S. Food ...
Reproductive cancer survivor beats disease, but is left with medical debt crisis
The Star Press via Yahoo News· 8 hours agoThis spring, stories related to health care will be featured. In March 2019, at 20 years old,...
Pfizer wins cancer drug patent case against AstraZeneca
Pharmaceutical Technology via Yahoo Finance· 3 days agoThe US District Court for the District of Delaware has ordered AstraZeneca to pay $107.5m to Pfizer...
AstraZeneca to reduce its reliance on China, build Singapore cancer drug plant
South China Morning Post· 3 days agoAntibody-drug conjugates have become an important part of Astra’s cancer push, showing the promise...
AstraZeneca and Nona Biosciences sign agreement for monoclonal antibody
Pharmaceutical Technology via Yahoo Finance· 4 hours agocancer patients.” In February 2024, Nona announced a collaboration with Boostimmune, focusing on the...
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a...
NBC San Diego· 4 hours agoTargeted radiopharmaceuticals has caught the eye of big pharma. The therapy delivers radiation...
AstraZeneca pays $19M to Harbour BioMed's Nona for preclinical cancer antibodies
FierceBiotech· 7 hours agoDays after AstraZeneca set out how new oncology drugs would help fuel its “bold” ambition to almost double its revenue by the end of the decade, the Big Pharma has further swelled this pipeline ...